APO Research
Talk to an analyst

APO RESEARCH · REPORT

Varbenazine Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Varbenazine Capsules Industry Growth and Trends Forecast to 2032

28 December 202591 pages

Choose your research edition.

Industry ResearchVarbenazine Capsules Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Varbenazine Capsules Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Varbenazine Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Varbenazine Capsules Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Varbenazine Capsules Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Varbenazine Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Varbenazine Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Varbenazine Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Varbenazine Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Varbenazine Capsules include Lupin, Neurocrine Biosciences, Zydus, Sandoz and Teva Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Varbenazine Capsules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Varbenazine Capsules market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Varbenazine Capsules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Varbenazine Capsules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Varbenazine Capsules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Varbenazine Capsules Market by Company

Lupin

Neurocrine Biosciences

Zydus

Sandoz

Teva Pharmaceuticals

Varbenazine Capsules Segment by Type

80mg per Unit

60mg per Unit

40mg per Unit

Varbenazine Capsules Segment by Application

Hospital and Clinic

Pharmacy

Other

Varbenazine Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Varbenazine Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Varbenazine Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Varbenazine Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Varbenazine Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Varbenazine Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 80mg per Unit Table 2. Major Company of 60mg per Unit Table 3. Major Company of 40mg per Unit Table 4. Global Varbenazine Capsules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Varbenazine Capsules Sales by Type (2021-2026) & (K Units) Table 6. Global Varbenazine Capsules Sales Market Share in Volume by Type (2021-2026) Table 7. Global Varbenazine Capsules Sales by Type (2021-2026) & (US$ Million) Table 8. Global Varbenazine Capsules Sales Market Share in Value by Type (2021-2026) Table 9. Global Varbenazine Capsules Price by Type (2021-2026) & (US$/Unit) Table 10. Global Varbenazine Capsules Sales by Type (2027-2032) & (K Units) Table 11. Global Varbenazine Capsules Sales Market Share in Volume by Type (2027-2032) Table 12. Global Varbenazine Capsules Sales by Type (2027-2032) & (US$ Million) Table 13. Global Varbenazine Capsules Sales Market Share in Value by Type (2027-2032) Table 14. Global Varbenazine Capsules Price by Type (2027-2032) & (US$/Unit) Table 15. North America Varbenazine Capsules Sales by Type (2021-2026) & (K Units) Table 16. North America Varbenazine Capsules Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Varbenazine Capsules Sales by Type (2021-2026) & (K Units) Table 18. Europe Varbenazine Capsules Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Varbenazine Capsules Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Varbenazine Capsules Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Varbenazine Capsules Sales by Type (2021-2026) & (K Units) Table 22. Latin America Varbenazine Capsules Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Varbenazine Capsules Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Varbenazine Capsules Sales by Type (2021-2026) & (US$ Million) Table 25. Varbenazine Capsules Industry Trends Table 26. Varbenazine Capsules Industry Drivers Table 27. Varbenazine Capsules Industry Opportunities and Challenges Table 28. Varbenazine Capsules Industry Restraints Table 29. Global Varbenazine Capsules Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Varbenazine Capsules Revenue Market Share by Company (2021-2026) Table 31. Global Varbenazine Capsules Sales by Company (2021-2026) & (K Units) Table 32. Global Varbenazine Capsules Sales Share by Company (2021-2026) Table 33. Global Varbenazine Capsules Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Varbenazine Capsules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Varbenazine Capsules Major Company Production Sites and Headquarters Table 36. Global Varbenazine Capsules Company, Product Type & Application Table 37. Global Varbenazine Capsules Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Varbenazine Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Varbenazine Capsules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Varbenazine Capsules Sales by Region (2021-2026) & (K Units) Table 42. Global Varbenazine Capsules Sales Market Share in Volume by Region (2021-2026) Table 43. Global Varbenazine Capsules Sales by Region (2021-2026) & (US$ Million) Table 44. Global Varbenazine Capsules Sales Market Share in Value by Region (2021-2026) Table 45. Global Varbenazine Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Varbenazine Capsules Sales by Region (2027-2032) & (K Units) Table 47. Global Varbenazine Capsules Sales Market Share in Volume by Region (2027-2032) Table 48. Global Varbenazine Capsules Sales by Region (2027-2032) & (US$ Million) Table 49. Global Varbenazine Capsules Sales Market Share in Value by Region (2027-2032) Table 50. Global Varbenazine Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Varbenazine Capsules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Varbenazine Capsules Sales by Application (2021-2026) & (K Units) Table 53. Global Varbenazine Capsules Sales Market Share in Volume by Application (2021-2026) Table 54. Global Varbenazine Capsules Sales by Application (2021-2026) & (US$ Million) Table 55. Global Varbenazine Capsules Sales Market Share in Value by Application (2021-2026) Table 56. Global Varbenazine Capsules Price by Application (2021-2026) & (US$/Unit) Table 57. Global Varbenazine Capsules Sales by Application (2027-2032) & (K Units) Table 58. Global Varbenazine Capsules Sales Market Share in Volume by Application (2027-2032) Table 59. Global Varbenazine Capsules Sales by Application (2027-2032) & (US$ Million) Table 60. Global Varbenazine Capsules Sales Market Share in Value by Application (2027-2032) Table 61. Global Varbenazine Capsules Price by Application (2027-2032) & (US$/Unit) Table 62. North America Varbenazine Capsules Sales by Application (2021-2026) & (K Units) Table 63. North America Varbenazine Capsules Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Varbenazine Capsules Sales by Application (2021-2026) & (K Units) Table 65. Europe Varbenazine Capsules Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Varbenazine Capsules Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Varbenazine Capsules Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Varbenazine Capsules Sales by Application (2021-2026) & (K Units) Table 69. Latin America Varbenazine Capsules Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Varbenazine Capsules Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Varbenazine Capsules Sales by Application (2021-2026) & (US$ Million) Table 72. Lupin Company Information Table 73. Lupin Business Overview Table 74. Lupin Varbenazine Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Lupin Varbenazine Capsules Product Portfolio Table 76. Lupin Recent Development Table 77. Neurocrine Biosciences Company Information Table 78. Neurocrine Biosciences Business Overview Table 79. Neurocrine Biosciences Varbenazine Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Neurocrine Biosciences Varbenazine Capsules Product Portfolio Table 81. Neurocrine Biosciences Recent Development Table 82. Zydus Company Information Table 83. Zydus Business Overview Table 84. Zydus Varbenazine Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Zydus Varbenazine Capsules Product Portfolio Table 86. Zydus Recent Development Table 87. Sandoz Company Information Table 88. Sandoz Business Overview Table 89. Sandoz Varbenazine Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Sandoz Varbenazine Capsules Product Portfolio Table 91. Sandoz Recent Development Table 92. Teva Pharmaceuticals Company Information Table 93. Teva Pharmaceuticals Business Overview Table 94. Teva Pharmaceuticals Varbenazine Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Teva Pharmaceuticals Varbenazine Capsules Product Portfolio Table 96. Teva Pharmaceuticals Recent Development Table 97. North America Varbenazine Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 98. North America Varbenazine Capsules Sales by Country (2021-2026) & (K Units) Table 99. North America Varbenazine Capsules Sales Market Share by Country (2021-2026) Table 100. North America Varbenazine Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 101. North America Varbenazine Capsules Sales Market Share Forecast by Country (2027-2032) Table 102. North America Varbenazine Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 103. North America Varbenazine Capsules Market Size by Country (2021-2026) & (US$ Million) Table 104. North America Varbenazine Capsules Market Share by Country (2021-2026) Table 105. North America Varbenazine Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 106. North America Varbenazine Capsules Market Share Forecast by Country (2027-2032) Table 107. Europe Varbenazine Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. Europe Varbenazine Capsules Sales by Country (2021-2026) & (K Units) Table 109. Europe Varbenazine Capsules Sales Market Share by Country (2021-2026) Table 110. Europe Varbenazine Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 111. Europe Varbenazine Capsules Sales Market Share Forecast by Country (2027-2032) Table 112. Europe Varbenazine Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. Europe Varbenazine Capsules Market Size by Country (2021-2026) & (US$ Million) Table 114. Europe Varbenazine Capsules Market Share by Country (2021-2026) Table 115. Europe Varbenazine Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. Europe Varbenazine Capsules Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Varbenazine Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Varbenazine Capsules Sales by Country (2021-2026) & (K Units) Table 119. Asia-Pacific Varbenazine Capsules Sales Market Share by Country (2021-2026) Table 120. Asia-Pacific Varbenazine Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 121. Asia-Pacific Varbenazine Capsules Sales Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Varbenazine Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Varbenazine Capsules Market Size by Country (2021-2026) & (US$ Million) Table 124. Asia-Pacific Varbenazine Capsules Market Share by Country (2021-2026) Table 125. Asia-Pacific Varbenazine Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Asia-Pacific Varbenazine Capsules Market Share Forecast by Country (2027-2032) Table 127. Latin America Varbenazine Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Latin America Varbenazine Capsules Sales by Country (2021-2026) & (K Units) Table 129. Latin America Varbenazine Capsules Sales Market Share by Country (2021-2026) Table 130. Latin America Varbenazine Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 131. Latin America Varbenazine Capsules Sales Market Share Forecast by Country (2027-2032) Table 132. Latin America Varbenazine Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Latin America Varbenazine Capsules Market Size by Country (2021-2026) & (US$ Million) Table 134. Latin America Varbenazine Capsules Market Share by Country (2021-2026) Table 135. Latin America Varbenazine Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Latin America Varbenazine Capsules Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Varbenazine Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Varbenazine Capsules Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Varbenazine Capsules Sales Market Share by Country (2021-2026) Table 140. Middle East and Africa Varbenazine Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 141. Middle East and Africa Varbenazine Capsules Sales Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Varbenazine Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Varbenazine Capsules Market Size by Country (2021-2026) & (US$ Million) Table 144. Middle East and Africa Varbenazine Capsules Market Share by Country (2021-2026) Table 145. Middle East and Africa Varbenazine Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Middle East and Africa Varbenazine Capsules Market Share Forecast by Country (2027-2032) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Varbenazine Capsules Distributors List Table 150. Varbenazine Capsules Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Varbenazine Capsules Image Figure 2. Global Varbenazine Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Varbenazine Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Varbenazine Capsules Sales (2021-2032) & (K Units) Figure 5. 80mg per Unit Image Figure 6. Global 80mg per Unit Sales YoY Growth (2021-2032) & (K Units) Figure 7. 60mg per Unit Image Figure 8. Global 60mg per Unit Sales YoY Growth (2021-2032) & (K Units) Figure 9. 40mg per Unit Image Figure 10. Global 40mg per Unit Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Varbenazine Capsules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Varbenazine Capsules Market Share by Type 2025 VS 2032 Figure 13. North America Varbenazine Capsules Sales Market Share in Volume by Type in 2025 Figure 14. North America Varbenazine Capsules Sales Market Share in Value by Type in 2025 Figure 15. Europe Varbenazine Capsules Sales Market Share in Volume by Type in 2025 Figure 16. Europe Varbenazine Capsules Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Varbenazine Capsules Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Varbenazine Capsules Sales Market Share in Value by Type in 2025 Figure 19. Latin America Varbenazine Capsules Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Varbenazine Capsules Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Varbenazine Capsules Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Varbenazine Capsules Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Varbenazine Capsules Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital and Clinic Image Figure 26. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Pharmacy Image Figure 28. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Varbenazine Capsules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Varbenazine Capsules Market Share by Application 2025 VS 2032 Figure 33. North America Varbenazine Capsules Sales Market Share in Volume by Application in 2025 Figure 34. North America Varbenazine Capsules Sales Market Share in Value by Application in 2025 Figure 35. Europe Varbenazine Capsules Sales Market Share in Volume by Application in 2025 Figure 36. Europe Varbenazine Capsules Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Varbenazine Capsules Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Varbenazine Capsules Sales Market Share in Value by Application in 2025 Figure 39. Latin America Varbenazine Capsules Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Varbenazine Capsules Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Varbenazine Capsules Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Varbenazine Capsules Sales Market Share in Value by Application in 2025 Figure 43. North America Varbenazine Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Varbenazine Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Varbenazine Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Varbenazine Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Varbenazine Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Varbenazine Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Varbenazine Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Varbenazine Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Varbenazine Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Varbenazine Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Varbenazine Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Varbenazine Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Varbenazine Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Varbenazine Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Varbenazine Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Varbenazine Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Varbenazine Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Varbenazine Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Varbenazine Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Varbenazine Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Varbenazine Capsules Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Varbenazine Capsules Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 80mg per Unit
  • 60mg per Unit
  • 40mg per Unit
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Lupin
  • Neurocrine Biosciences
  • Zydus
  • Sandoz
  • Teva Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Varbenazine Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Varbenazine Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Varbenazine Capsules Market by Type
  6. 1.3.1 80mg per Unit
  7. 1.3.2 60mg per Unit
  8. 1.3.3 40mg per Unit
  9. 1.4 Global Varbenazine Capsules Market Size by Type
  10. 1.4.1 Global Varbenazine Capsules Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Varbenazine Capsules Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Varbenazine Capsules Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Varbenazine Capsules Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Varbenazine Capsules Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Varbenazine Capsules Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Varbenazine Capsules Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Varbenazine Capsules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Varbenazine Capsules Industry Trends
  2. 2.2 Varbenazine Capsules Industry Drivers
  3. 2.3 Varbenazine Capsules Industry Opportunities and Challenges
  4. 2.4 Varbenazine Capsules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Varbenazine Capsules Revenue (2021-2026)
  2. 3.2 Global Top Players by Varbenazine Capsules Sales (2021-2026)
  3. 3.3 Global Top Players by Varbenazine Capsules Price (2021-2026)
  4. 3.4 Global Varbenazine Capsules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Varbenazine Capsules Major Company Production Sites & Headquarters
  6. 3.6 Global Varbenazine Capsules Company, Product Type & Application
  7. 3.7 Global Varbenazine Capsules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Varbenazine Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Varbenazine Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Varbenazine Capsules Tier 1, Tier 2, and Tier 3
4 Varbenazine Capsules Regional Status and Outlook
  1. 4.1 Global Varbenazine Capsules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Varbenazine Capsules Historic Market Size by Region
  3. 4.2.1 Global Varbenazine Capsules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Varbenazine Capsules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Varbenazine Capsules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Varbenazine Capsules Forecasted Market Size by Region
  7. 4.3.1 Global Varbenazine Capsules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Varbenazine Capsules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Varbenazine Capsules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Varbenazine Capsules by Application
  1. 5.1 Varbenazine Capsules Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Varbenazine Capsules Market Size by Application
  6. 5.2.1 Global Varbenazine Capsules Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Varbenazine Capsules Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Varbenazine Capsules Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Varbenazine Capsules Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Varbenazine Capsules Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Varbenazine Capsules Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Varbenazine Capsules Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Varbenazine Capsules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Lupin
  2. 6.1.1 Lupin Company Information
  3. 6.1.2 Lupin Business Overview
  4. 6.1.3 Lupin Varbenazine Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Lupin Varbenazine Capsules Product Portfolio
  6. 6.1.5 Lupin Recent Developments
  7. 6.2 Neurocrine Biosciences
  8. 6.2.1 Neurocrine Biosciences Company Information
  9. 6.2.2 Neurocrine Biosciences Business Overview
  10. 6.2.3 Neurocrine Biosciences Varbenazine Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Neurocrine Biosciences Varbenazine Capsules Product Portfolio
  12. 6.2.5 Neurocrine Biosciences Recent Developments
  13. 6.3 Zydus
  14. 6.3.1 Zydus Company Information
  15. 6.3.2 Zydus Business Overview
  16. 6.3.3 Zydus Varbenazine Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Zydus Varbenazine Capsules Product Portfolio
  18. 6.3.5 Zydus Recent Developments
  19. 6.4 Sandoz
  20. 6.4.1 Sandoz Company Information
  21. 6.4.2 Sandoz Business Overview
  22. 6.4.3 Sandoz Varbenazine Capsules Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sandoz Varbenazine Capsules Product Portfolio
  24. 6.4.5 Sandoz Recent Developments
  25. 6.5 Teva Pharmaceuticals
  26. 6.5.1 Teva Pharmaceuticals Company Information
  27. 6.5.2 Teva Pharmaceuticals Business Overview
  28. 6.5.3 Teva Pharmaceuticals Varbenazine Capsules Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Teva Pharmaceuticals Varbenazine Capsules Product Portfolio
  30. 6.5.5 Teva Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Varbenazine Capsules Sales by Country
  2. 7.1.1 North America Varbenazine Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Varbenazine Capsules Sales by Country (2021-2026)
  4. 7.1.3 North America Varbenazine Capsules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Varbenazine Capsules Market Size by Country
  6. 7.2.1 North America Varbenazine Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Varbenazine Capsules Market Size by Country (2021-2026)
  8. 7.2.3 North America Varbenazine Capsules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Varbenazine Capsules Sales by Country
  2. 8.1.1 Europe Varbenazine Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Varbenazine Capsules Sales by Country (2021-2026)
  4. 8.1.3 Europe Varbenazine Capsules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Varbenazine Capsules Market Size by Country
  6. 8.2.1 Europe Varbenazine Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Varbenazine Capsules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Varbenazine Capsules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Varbenazine Capsules Sales by Country
  2. 9.1.1 Asia-Pacific Varbenazine Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Varbenazine Capsules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Varbenazine Capsules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Varbenazine Capsules Market Size by Country
  6. 9.2.1 Asia-Pacific Varbenazine Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Varbenazine Capsules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Varbenazine Capsules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Varbenazine Capsules Sales by Country
  2. 10.1.1 South America Varbenazine Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Varbenazine Capsules Sales by Country (2021-2026)
  4. 10.1.3 South America Varbenazine Capsules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Varbenazine Capsules Market Size by Country
  6. 10.2.1 South America Varbenazine Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Varbenazine Capsules Market Size by Country (2021-2026)
  8. 10.2.3 South America Varbenazine Capsules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Varbenazine Capsules Sales by Country
  2. 11.1.1 Middle East and Africa Varbenazine Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Varbenazine Capsules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Varbenazine Capsules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Varbenazine Capsules Market Size by Country
  6. 11.2.1 Middle East and Africa Varbenazine Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Varbenazine Capsules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Varbenazine Capsules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Varbenazine Capsules Value Chain Analysis
  2. 12.1.1 Varbenazine Capsules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Varbenazine Capsules Production Mode & Process
  7. 12.2 Varbenazine Capsules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Varbenazine Capsules Distributors
  10. 12.2.3 Varbenazine Capsules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst